Tag Archives: The Stem Cell Blog

Video: Meet the CEO developing Gene Therapy without Viral Vectors – Labiotech.eu (blog)

Continue reading

2017-05-11 NEWS

Labiotech.eu (blog)

Video: Meet the CEO developing Gene Therapy without Viral Vectors
Labiotech.eu (blog)
Eyevensys has found a way to deliver gene therapy without viral vectors. Clara caught up with the company’s CEO Raffy Kazandjian at BioTrinity to hear more. Eyevensys is based in Paris and has set itself the mission of enhancing current treatment

and more »

Continue reading

2017-05-11 NEWS

FDA Nod For MRK’s Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes
Nasdaq
Shares of Sangamo Therapeutics Inc. (SGMO) were up 44.83% to $6.30 in extended trading on Wednesday, following a global collaboration with Pfizer Inc. (PFE) for Hemophilia A gene therapy. The agreement also covers SB-525, one of Sangamo’s four lead …

Continue reading

2017-05-11 NEWS

Stem Cells for Zoos: Conservation with Cellular Technologies
Labiotech.eu (blog)
Stem cells are recognized for their therapeutic promise in regenerative medicine, and they’re also being used to save endangered species! Four hours north of Nairobi, closely safeguarded by armed security, the last remaining northern white rhinoceros

and more »

Continue reading

2017-05-11 NEWS

Indianapolis Star

AJ Foyt on fear, his stem cell therapy and more
Indianapolis Star
It’s been a long and wild ride, and A.J. Foyt has enjoyed nearly every second of it. “I had a lot of fun,” the 82-year-old racing legend told IndyStar on Wednesday at his racing garage in Speedway. “If I passed out talking to you right now and fell on

and more »

Continue reading

2017-05-10 NEWS

U.S. News & World Report

U.S. FDA Approves Merck Immunotherapy/chemo Combo for Lung Cancer
U.S. News & World Report
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009, after Merck & Co Inc said it would acquire Schering-Plough Corp in $41.1 billion deal, widening Merck’s pipeline and diversifying its portfolio of medicines. REUTERS/Jeff Zelevansky …
Merck Extends Immunotherapy Lead With Lung Cancer Combination Therapy ApprovalTheStreet.com
Merck Immunotherapy Drug Notches Another FDA Win in Lung CancerXconomy
FDA approves Merck immunotherapy/chemo combo for lung cancerChannel NewsAsia
Curetoday.com –BioPharma Dive
all 33 news articles »